Charles F Albright

Title: Charles F Albright: Innovator in Tau-Associated Disease Treatments

Introduction

Charles F Albright is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of medical research, particularly in the treatment of tau-associated diseases, including Alzheimer's disease. With a total of 2 patents, Albright's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

Albright's latest patents include innovative methods for treating tau-associated diseases. One of his key patents focuses on the use of epothilone D, which demonstrates good brain penetration, a long half-life, and high selective retention in the brain. This method provides effective therapies for treating tauopathies, including Alzheimer's disease. Another patent involves in vitro cell-based methods for identifying compounds that inhibit Notch cleavage. This includes methods for identifying γ-secretase inhibitors that exhibit reduced induction of goblet cell metaplasia, as well as methods for identifying compounds that inhibit cleavage of γ-secretase substrates other than Notch.

Career Highlights

Charles F Albright is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and treatment of complex neurological diseases.

Collaborations

Albright has collaborated with notable colleagues, including Donna Marie Barten and Francis Lee. These collaborations have further enriched his research and expanded the scope of his innovations.

Conclusion

Charles F Albright's contributions to the field of medical research, particularly in the treatment of tau-associated diseases, highlight his role as an influential inventor. His innovative patents and ongoing work at Bristol-Myers Squibb Company continue to pave the way for advancements in healthcare.